Max India (NSE:MAXIND) 5-Year Yield-on-Cost %: 0.00 (As of Aug. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MAXIND Max India Ltd NSE:MAXIND
64 GF Score
Price ₹171.08
GF Value ₹204.93
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Max India 5-Year Yield-on-Cost %?

Max India NSE:MAXIND -1.01% 64 5-Year Yield-on-Cost % is 0.00 as of Aug. 09, 2026. GuruFocus rates NSE:MAXIND with a GF Score™ of 64/100 and a GF Value™ of ₹204.93 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 275 Healthcare Providers & Services companies, Max India ranks worse than 363636% on this metric.

Max India's yield on cost for the quarter that ended in Mar. 2026 was 0.00.


The historical rank and industry rank for Max India's 5-Year Yield-on-Cost % or its related term are showing as below:



NSE:MAXIND's 5-Year Yield-on-Cost % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.9
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Max India  (NSE:MAXIND) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Max India 5-Year Yield-on-Cost % Related Terms


NSE:MAXIND vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison

For the Medical Care Facilities subindustry, Max India's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Max India 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Max India's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Max India's 5-Year Yield-on-Cost % falls into.


NSE:MAXIND
64GF Score
Max India Ltd NSE:MAXIND
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Max India 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Max India is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Max India (NSE:MAXIND) has a 5-Year Yield-on-Cost % of 0.00 as of Aug. 09, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Max India and its competitors. According to the industry distribution chart, Max India ranks #999999 out of 275 companies in the Healthcare Providers & Services industry.
Is Max India's 5-Year Yield-on-Cost % too high?
Max India's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Max India ranks #999999 out of 275 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Max India has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Max India's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Max India ranks #999999 out of 275 companies for 5-Year Yield-on-Cost %. This places Max India in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.90, based on 275 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Max India and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Max India's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Max India stock overvalued right now?
Based on GuruFocus' analysis, Max India (NSE:MAXIND) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹204.93, compared to a current price of ₹171.08 — trading 16.5% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Max India's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Max India (NSE:MAXIND), the current 5-Year Yield-on-Cost % is 0.00 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Max India (NSE:MAXIND) Overvalued in 2026?

Based on GuruFocus' analysis, Max India stock appears to be undervalued. The current stock price of ₹171.08 is trading 16.5% below its estimated GF Value™ of ₹204.93. GuruFocus considers Max India to be Modestly Undervalued.

Key valuation signals for NSE:MAXIND:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: ₹204.93 vs. price of ₹171.08 (16.5% below fair value)
  • GF Score™: 64/100 with 4 warning signs

No single metric tells the full story. See the NSE:MAXIND stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Max India Business Description

Other Exchanges 543223:India
Address Landmark House, Plot No- 65, 3rd Floor, Sector- 44, Gurugram, HR, IND, 122003
Max India Ltd is a multi-business corporate that operates in the healthcare sector. The company provides healthcare services. Also, the company provides health insurance policies, senior-living communities, and other health-related training services. The business operates in four segments namely, Business Investments, Senior Living, Assisted Care, and Other. It derives maximum revenue from Senior Living segment.
64GF Score

Get the complete analysis for NSE:MAXIND

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹171.08
Price
₹204.93
GF Value